1852 related articles for article (PubMed ID: 30962421)
21. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
Viswanathan VS; Ryan MJ; Dhruv HD; Gill S; Eichhoff OM; Seashore-Ludlow B; Kaffenberger SD; Eaton JK; Shimada K; Aguirre AJ; Viswanathan SR; Chattopadhyay S; Tamayo P; Yang WS; Rees MG; Chen S; Boskovic ZV; Javaid S; Huang C; Wu X; Tseng YY; Roider EM; Gao D; Cleary JM; Wolpin BM; Mesirov JP; Haber DA; Engelman JA; Boehm JS; Kotz JD; Hon CS; Chen Y; Hahn WC; Levesque MP; Doench JG; Berens ME; Shamji AF; Clemons PA; Stockwell BR; Schreiber SL
Nature; 2017 Jul; 547(7664):453-457. PubMed ID: 28678785
[TBL] [Abstract][Full Text] [Related]
22. Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)-dependent stabilization of hypoxia-inducible factor 1-α and 2-α.
Yi Z; Jiang L; Zhao L; Zhou M; Ni Y; Yang Y; Yang H; Yang L; Zhang Q; Kuang Y; Deng M; Zhu Y
J Cell Biochem; 2019 Nov; 120(11):19124-19136. PubMed ID: 31310363
[TBL] [Abstract][Full Text] [Related]
23. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
24. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
Fan Y; Li H; Ma X; Gao Y; Bao X; Du Q; Ma M; Liu K; Yao Y; Huang Q; Zhang Y; Zhang X
Oncotarget; 2016 Apr; 7(14):18280-94. PubMed ID: 26943772
[TBL] [Abstract][Full Text] [Related]
25. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
[TBL] [Abstract][Full Text] [Related]
26. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
Forcina GC; Dixon SJ
Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.
Xu J; Wang B; Xu Y; Sun L; Tian W; Shukla D; Barod R; Grillari J; Grillari-Voglauer R; Maxwell PH; Esteban MA
Oncogene; 2012 Feb; 31(8):1065-72. PubMed ID: 21841824
[TBL] [Abstract][Full Text] [Related]
28. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
Harashima N; Takenaga K; Akimoto M; Harada M
Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
[TBL] [Abstract][Full Text] [Related]
29. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis.
Zou Y; Li H; Graham ET; Deik AA; Eaton JK; Wang W; Sandoval-Gomez G; Clish CB; Doench JG; Schreiber SL
Nat Chem Biol; 2020 Mar; 16(3):302-309. PubMed ID: 32080622
[TBL] [Abstract][Full Text] [Related]
32. Role of GPX4 in ferroptosis and its pharmacological implication.
Seibt TM; Proneth B; Conrad M
Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
[TBL] [Abstract][Full Text] [Related]
33. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
34. The uremic toxin p-cresyl sulfate induces proliferation and migration of clear cell renal cell carcinoma via microRNA-21/ HIF-1α axis signals.
Wu TK; Wei CW; Pan YR; Hsu RJ; Wu CY; Yu YL
Sci Rep; 2019 Mar; 9(1):3207. PubMed ID: 30824757
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
[TBL] [Abstract][Full Text] [Related]
36. Correlation between BOLD-MRI and HIF expression level in renal carcinoma.
Li D; Wang X; Wang S; Cheng J
Int J Clin Exp Pathol; 2015; 8(10):13759-63. PubMed ID: 26722605
[TBL] [Abstract][Full Text] [Related]
37. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma.
David JM; Owens TA; Inge LJ; Bremner RM; Rajasekaran AK
Mol Cancer Ther; 2014 Apr; 13(4):788-99. PubMed ID: 24493697
[TBL] [Abstract][Full Text] [Related]
38. Endogenous HIF2A reporter systems for high-throughput functional screening.
Zaini MN; Patel SA; Syafruddin SE; Rodrigues P; Vanharanta S
Sci Rep; 2018 Aug; 8(1):12063. PubMed ID: 30104738
[TBL] [Abstract][Full Text] [Related]
39. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.
Elorza A; Soro-Arnáiz I; Meléndez-Rodríguez F; Rodríguez-Vaello V; Marsboom G; de Cárcer G; Acosta-Iborra B; Albacete-Albacete L; Ordóñez A; Serrano-Oviedo L; Giménez-Bachs JM; Vara-Vega A; Salinas A; Sánchez-Prieto R; Martín del Río R; Sánchez-Madrid F; Malumbres M; Landázuri MO; Aragonés J
Mol Cell; 2012 Dec; 48(5):681-91. PubMed ID: 23103253
[TBL] [Abstract][Full Text] [Related]
40. [Silencing hypoxia inducible factor-2α gene by small interference RNA inhibits the growth of mammosphere cells in nude mice under hypoxic microenvironment].
Qu HB; Fan YM; Han ML; Zeng N; Zhu ZK; Liu H; Xie J; Wu CY; Tang WX
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1182-7. PubMed ID: 23902893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
